Literature DB >> 2044713

Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.

W Kaca1, A Rózalski.   

Abstract

The relationship between growth condition and production of cell-bound hemolysin by Proteus mirabilis S1959 strain was investigated. Hemolytic activity was not dependent on type of medium, oxygen accessibility and was inhibited in presence of N-ethylmaleimide, different sera or trypsine. Cell-free hemolysin was released to the medium during stationary-death phases of growth of fluid Proteus mirabilis and vulgaris cultures.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2044713     DOI： 10.1007/bf00237360

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  14 in total

Review 1.  Secretion of haemolysin by Escherichia coli.

Authors:  N Mackman; J M Nicaud; L Gray; I B Holland
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

2.  Production and properties of haemolysins from clinical isolates of the Proteeae.

Authors:  B W Senior; C Hughes
Journal:  J Med Microbiol       Date:  1988-01       Impact factor: 2.472

3.  The HpmA hemolysin is more common than HlyA among Proteus isolates.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Hemolytic activity and invasiveness in strains of Proteus penneri.

Authors:  A Rozalski; K Kotełko
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

Review 5.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

6.  Identification of two different hemolysin determinants in uropathogenic Proteus isolates.

Authors:  R A Welch
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Vero cell invasiveness of Proteus mirabilis.

Authors:  P G Peerbooms; A M Verweij; D M MacLaren
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.

Authors:  P G Peerbooms; A M Verweij; D M MacLaren
Journal:  J Med Microbiol       Date:  1985-02       Impact factor: 2.472

9.  Investigation of the haemolytic activity of Proteus mirabilis strains.

Authors:  P G Peerbooms; A M Verweij; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1983-04       Impact factor: 2.271

10.  Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.

Authors:  K Kotelko; W Kaca; A Rózalski; M Deka
Journal:  Acta Microbiol Pol       Date:  1983
View more
  4 in total

Review 1.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 2.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

Review 3.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

4.  Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.

Authors:  Praveen Alamuri; Kathryn A Eaton; Stephanie D Himpsl; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.